Article info
Education in Heart
Thrombo-embolic venous disease
Non-vitamin K antagonist oral anticoagulants (NOACs) for the management of venous thromboembolism
- Correspondence to Professor Gregory Y H Lip, University of Birmingham Institute for Cardiovascular Disease, City Hospital, Birmingham, B18 7QH, UK; g.y.h.lip{at}bham.ac.uk
Citation
Non-vitamin K antagonist oral anticoagulants (NOACs) for the management of venous thromboembolism
Publication history
- First published March 16, 2016.
Online issue publication
June 06, 2016
Article Versions
- Previous version (27 May 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/